Evolution of the European Medicines Agency clinical guidelines for epilepsy drug development between 2010 and 2025: A comparative analysis by the ILAE Task Force on Regulatory Affairs.

Auvin S et al.

NCBI PubMed Central · Papers · License: Open Access

legal informatics

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 305165
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.